PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA

Detalles Bibliográficos
Autores principales: Ding, Yuehua, Lu, Minqiu, Chu, Bin, Shi, Lei, Gao, Shan, Xiang, Qiuqing, Fang, Lijuan, Wang, Yutong, Liu, XI, Zhao, Xin, Wang, Mengzhen, Chen, Yuan, Kai, Sun, Bao, LI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429744/
http://dx.doi.org/10.1097/01.HS9.0000975328.40621.c2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429744/
http://dx.doi.org/10.1097/01.HS9.0000975328.40621.c2

Ejemplares similares